Inhibition of uridine phosphorylase. Synthesis and structure-activity relationships of aryl-substituted 1-((2-hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracil. 1997

G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
Division of Organic Chemistry, Glaxo Wellcome Inc., Research Triangle Park, North Carolina 27709, USA.

Structure-activity relationship studies on a series of 1-((2-hydroxyethoxy)methyl)-5-(3-(substituted-phenoxy)benzyl)uracils as inhibitors of murine liver uridine phosphorylase have led to compounds with IC50s as low as 1.4 nM. The two most potent compounds, 10j (3-cyanophenoxy) and 11f (3-chlorophenoxy) were tested in vivo for effects on steady-state concentrations of circulating uridine in mice and rats. Both compounds were substantially more efficacious than BAU (5-benzylacyclouridine) both in vitro and in vivo.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D014543 Uridine Phosphorylase An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate. 5-Fluoro-2'-deoxyuridine Phosphorylase,5 Fluoro 2' deoxyuridine Phosphorylase,Phosphorylase, 5-Fluoro-2'-deoxyuridine,Phosphorylase, Uridine
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
January 1988, Annals of the New York Academy of Sciences,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
February 1996, Journal of medicinal chemistry,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
November 1990, Archiv der Pharmazie,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
November 1989, Arzneimittel-Forschung,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
April 1991, Journal of medicinal chemistry,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
April 2012, Archiv der Pharmazie,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
January 1988, Annals of the New York Academy of Sciences,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
January 2001, Nucleosides, nucleotides & nucleic acids,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
October 2003, Bioorganic & medicinal chemistry letters,
G F Orr, and D L Musso, and J L Kelley, and S S Joyner, and S T Davis, and D P Baccanari
March 1982, Biochemical pharmacology,
Copied contents to your clipboard!